IPO Radar

Every company that just registered to go public (Form S-1) or priced its IPO (Form 424B4), pulled straight from SEC filings — SPACs and blank-check shells removed. Open any one for a plain-English AI read of its prospectus: what it does, the strengths it claims, and the risks it discloses. Educational only, never a buy/sell call.

★ NOW PUBLICHNUCNuclear energy / SMRs

Holtec Nuclear Corp

Small modular reactor (SMR) developer and nuclear services company founded by Kris Singh (predecessor business dates to 1986). Owns the Palisades plant in Michigan and holds access to four other US nuclear sites for its SMR-300 program; the only SMR developer picked by the DOE for a Tier 1 First Mover Award, which it expects will bring a $400M grant toward its first dual-unit SMR-300 plant.

IPO price
Not yet disclosed — initial S-1 filed without a price range
Size
Not yet disclosed
Status
Public — trading on Nasdaq as HNUC
Read the prospectus breakdown →
★ NOW PUBLICMENWApparel retail

Tailored Brands, Inc.

Parent of Men’s Wearhouse, Jos. A. Bank, Moores and K&G — the men’s formalwear and suiting retailer that went through a 2020 financial restructuring (over 400 stores closed) and has been majority-owned by credit investor Silver Point Capital since 2021.

IPO price
Not yet disclosed — initial S-1 filed without a price range
Size
Not yet disclosed
Status
Public — trading on Nasdaq as MENW
Read the prospectus breakdown →
★ NOW PUBLICAPMDPharmaceuticals

Apnimed, Inc.

Late-stage clinical pharmaceutical company developing novel oral therapies for the neurobiology of sleep-related breathing diseases. Its lead program, AD109 (proposed brand name Oxnimbi), targets obstructive sleep apnea (OSA) — a would-be pill alternative to CPAP machines and devices.

IPO price
Not yet disclosed — initial S-1 filed without a price range
Size
Not yet disclosed
Status
Public — trading on Nasdaq as APMD
Read the prospectus breakdown →
★ NOW PUBLICSCTXBiotech

Scribe Therapeutics, Inc.

Clinical-stage biotech engineering in vivo CRISPR gene-editing therapies aimed at disease prevention and durable treatment. Its lead program, STX-1150, targets potent and persistent LDL-C (“bad” cholesterol) lowering via a single-course edit rather than a daily drug.

IPO price
Not yet disclosed — initial S-1 filed without a price range
Size
Not yet disclosed
Status
Public — trading on Nasdaq as SCTX
Read the prospectus breakdown →
JUST PRICED · 6
Sunshine Biopharma Inc.SBFMPharmaceuticals · 424B4 · COPriced2026-10-09DarkIris Inc.DKISoftware · 424B4Priced2026-10-09Retension Pharmaceuticals, Inc.Pharmaceuticals · 424B4 · DEPriced2026-10-09TRex Bio, Inc.Biotech · 424B4 · DEPriced2026-10-09Basel Medical Group LtdBMGL424B4 · D8Priced2026-10-08Accelevation Holdings Corp.ACCV424B4 · DEPriced2026-10-01
RECENTLY REGISTERED · 54
Bambusa Therapeutics, Inc.Biotech · S-1 · DERegistered2026-10-09SPECIFICITY, INC.SPTYS-1 · NVRegistered2026-10-09GT Biopharma, Inc.GTBPPharmaceuticals · S-1 · DERegistered2026-10-09DataMeds AI, Inc.MEDSS-1/A · DERegistered2026-10-09BirchBioMed Inc.Pharmaceuticals · S-1/A · A1Registered2026-10-09FingerMotion, Inc.FNGRSoftware · S-1/A · DERegistered2026-10-09BIO KEY INTERNATIONAL INCBKYISoftware · S-1 · DERegistered2026-10-09SeeQC, Inc.SEQCData & IT services · S-1/A · DERegistered2026-10-09Simwon America Corp.Autos · S-1 · CARegistered2026-10-09PBT Land & Minerals, Inc.S-1/A · TXRegistered2026-10-09Aspen Neuroscience, Inc.Pharmaceuticals · S-1 · DERegistered2026-10-09Patriot Mobile Inc.S-1 · TXRegistered2026-10-09CITY THERAPEUTICS, INC.CTYPharmaceuticals · S-1/A · DERegistered2026-10-09Kainan Holding Group LtdKHGF-1/A · D8Registered2026-10-09LORENZO DEVELOPMENTS INC.F-1/A · Z4Registered2026-10-09OPAY LtdF-1 · E9Registered2026-10-09vVARDIS Holding AGMedical devices · F-1 · V8Registered2026-10-09Nexalin Technology, Inc.NXLS-1/A · DERegistered2026-10-08CYABRA, INC.CYABSoftware · S-1 · DERegistered2026-10-08Amaero Inc.AMROS-1/A · DERegistered2026-10-08Iambic Therapeutics, Inc.Biotech · S-1/A · DERegistered2026-10-08707 Cayman Holdings Ltd.JEMF-1/A · K3Registered2026-10-08Tracx Logis Ltd.TRCXF-1/A · U0Registered2026-10-08FireFly Robotics, Inc.S-1 · DERegistered2026-10-07Elements Ventures Group Inc.S-1/A · WYRegistered2026-10-07VS TrustSVIXCommodity brokers · S-1/A · DERegistered2026-10-07Decoy Therapeutics Inc.DCOYPharmaceuticals · S-1 · DERegistered2026-10-07Centinel Spine Holdco, Inc.Medical devices · S-1 · DERegistered2026-10-07ACTUATE THERAPEUTICS, INC.ACTUPharmaceuticals · S-1 · DERegistered2026-10-06Fusemachines Inc.FUSES-1Registered2026-10-06NON INVASIVE MONITORING SYSTEMS INCNIMUS-1/A · FLRegistered2026-10-06Pluri Inc.PLURBiotech · S-1 · NVRegistered2026-10-06GridAI Technologies Corp.GRDXUtilities · S-1/A · DERegistered2026-10-06Winklevoss Zcash ETFS-1 · DERegistered2026-10-06newcleo plcNWCLF-1 · X0Registered2026-10-06Silentium Ltd.SIAISoftware · F-1/A · L3Registered2026-10-06Lycia Therapeutics, Inc.Biotech · S-1 · DERegistered2026-10-05Propanc Biopharma, Inc.PPCBPharmaceuticals · S-1 · DERegistered2026-10-05Rothe Development, Inc.S-1/A · TXRegistered2026-10-05Evolution Metals & Technologies Corp.EMATElectronics · S-1 · DERegistered2026-10-05Neuro Spectrum Insights, Inc.Medical devices · S-1/A · DERegistered2026-10-05DayOne Data Centers LtdSoftware & IT · F-1 · E9Registered2026-10-05Canary PEPE ETFCommodity brokers · S-1/A · DERegistered2026-10-02Youmi Inc.S-1/A · NVRegistered2026-10-02Vertical Data Inc.VDTAS-1 · NVRegistered2026-10-02HCW Biologics Inc.HCWBPharmaceuticals · S-1 · DERegistered2026-10-02BioStem Technologies, Inc.BSEMBiotech · S-1 · FLRegistered2026-10-02T3 Defense Inc.DFNSS-1/A · DERegistered2026-10-02GEORGIA BANKING CO INCS-1 · GARegistered2026-10-02LPC LTDF-1Registered2026-10-02CitroTech Inc.CITRS-1/A · WYRegistered2026-10-01Uranium Royalty Corp.UROYCommodity brokers · S-1 · DERegistered2026-10-01INTERPACE BIOSCIENCES, INC.IDXGMedical devices · S-1/A · DERegistered2026-10-01WhiteHawk Minerals Corp.WHKOil & gas · S-1 · DERegistered2026-10-01

Source: SEC EDGAR full-text search (S-1, S-1/A, 424B4). We remove blank-check/SPAC shells (SIC 6770). An S-1 registration is not a guarantee a company will complete an IPO, or when. Educational only — not financial advice.